Drug Database
IN

INJEX system

✓ Approved

Equidyne · therapeutic agent

What is INJEX system?

INJEX system is a therapeutic agent developed by Equidyne. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection or subcutaneous injection.

Drug Profile

CompanyEquidyne
RouteInjectable (Others), Intramuscular (IM) Injection, Subcutaneous Injection
StatusApproved

Therapeutic Indications

INJEX system is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Surgical and medical proceduresOral appliance application✓ Approved

Related Research Articles

PubMedMedecine sciences : M/S2026-07-17

[Development, morphogenesis, and regeneration of cardiac Purkinje fibers].

Boulgakoff Lucie L, Miquerol Lucile L

Ventricular arrhythmias often originate in the Purkinje system, a network of specialized cardiomyocytes located on the luminal surface of the ventricles. The Purkinje system is part of the ventricular conduction system, which ensures the rapid propagation of electrical activity through the ventricles in order to synchronize their contractions. Although these cells represent only a tiny fraction of the ventricular mass, their pathogenic role is disproportionate. During embryogenesis, the ventricular conduction system arises from different populations of cardiac progenitors. Differentiation into fast-conducting cardiomyocytes occurs gradually as the ventricles develop, resulting in the formation of a single electrical circuit by the end of the fetal stage. This review highlights the structure-function relationship between the morphogenesis of the ventricular conduction system and conduction defects, and discusses recent data on the origin, development, and regeneration of the Purkinje fiber network.

PubMedScientific reports2026-07-17

Cascaded adaptive load frequency control for single area and double area power systems considering wind penetration.

El-Bassiouny Ahmed A, Attia Mahmoud A MA, Hamouda Rizk R, Hamouda Mohamed R MR

This study investigates the application of a cascaded adaptive controller for Load Frequency Control (LFC) in single-area and two-area power systems. The controller is a combination between adaptive PI controller and PID controller thus the term cascaded controller. The main objective is to evaluate the controller's performance under various operating conditions through comparison with a conventional controller and adaptive controller. The case studies in the single-area power system shall be four case studies to be examined: (1) a conventional system without renewable energy integration, (2) a system with wind power introduced as a disturbance source, and (3) and (4) modified versions of the first two cases excluding time-delay effects. Similarly, the two-area power system is analyzed using four case studies, for the first and second scenarios, a static load change is applied independently to each area, while the third and fourth scenarios extend these cases by considering dynamic, time-varying load changes. For all scenarios, disturbances are introduced in one area, and their effects on tie-line power flow are analyzed. An optimization algorithm is utilized to determine the optimal gain parameters for each controller configuration. MATLAB/Simulink is employed for system simulation, and the system responses are assessed in the time domain. Simulation results demonstrate that the proposed cascaded adaptive controller exhibits superior performance and robustness, particularly in disturbance rejection and frequency stability enhancement. As there is an improvement in the system response by minimizing overshoot, reducing oscillations, and achieving faster settling times-outperforming traditional PI, standalone AFOPI, and PID controllers indicating that it can be utilized in different power systems.

PubMedClinical oral investigations2026-07-17

Deep learning-based automated assessment of alveolar bone loss in CBCT for periodontitis.

Wang Yuyan Y, Zheng Hongjie H, Duan Xinyu X, Li Yihong Y et al.

This study aimed to develop and validate a CBCT-based automated system for assessing radiographic alveolar bone loss (RBL) to improve the accuracy and efficiency of periodontitis diagnosis. A total of 110 patients (2,796 teeth) with Stage I-IV periodontitis from four center were included. The nnU-Net framework was used to segment teeth, alveolar bone, and the cemento-enamel junction (CEJ). RBL was calculated automatically using an edge-constrained shortest path algorithm. The model was trained on data from Center A and externally validated with datasets from Centers B-D. Linear periodontal measurements from 11 CBCT scans were compared between manual and CAD-based segmentation. An independent validation set was used to assess automated staging accuracy and time efficiency. The CAD system achieved Dice similarity coefficients (DSC) of 95.85% for teeth, 95.75% for alveolar bone, and 86.18% for the CEJ. External validation showed alveolar bone and tooth DSC values both above 95% and CEJ DSC values above 77%. Linear measurements showed strong agreement with manual segmentation (Spearman's ρ = 0.9187; ICC = 0.9266). For staging, the CAD system reached an overall accuracy of 87.31%, with 97.01% for Stage Ⅰ, 88.06% for Stage Ⅱ and 89.55% for Stage Ⅲ/Ⅳ. The CAD system represented a 13.42-fold acceleration compared with the manual workflow. The CAD system enables accurate automated segmentation and RBL quantification on CBCT images, with robust multicenter performance and substantial gains in efficiency. This system offers a fast and reliable method for RBL assessment, supporting consistent diagnosis and monitoring of periodontitis.

PubMedFrontiers in systems neuroscience2026-07-17

Editorial: Understanding neural processing as an integrated intelligent system.

Werbos Paul J PJ, Wack David S DS, Slavakis Konstantinos K, Badgaiyan Rajendra D RD

PubMedLuminescence : the journal of biological and chemical luminescence2026-07-17

A Sustainable 3D-Printed Electrochemiluminescence Microcell With an Integrated Three-Electrode System for Gallic Acid Determination.

Promsen Kraiwit K, Chaiyahan Panphailin P, Tangkuaram Tanin T, Kitikul Jiraporn J et al.

This work presents a sustainable, fully 3D-printed electrochemiluminescence (ECL) microcell with an integrated three-electrode system for the sensitive determination of gallic acid. The device comprises a biodegradable polylactic acid (PLA) microcell integrated with a three-electrode system fabricated from carbon black-loaded PLA, enabling compact and low-cost electrochemical measurements. A luminol-based ECL system in carbonate buffer was employed, with carbon dots (CDs) introduced to enhance emission intensity by promoting electron transfer and reactive oxygen species generation, thereby amplifying the chemiexcitation pathway. The working electrode was modified with Prussian blue to improve electrochemical performance, while a pseudo-Ag/AgCl reference electrode ensured stable potential control. Under optimized conditions, the platform exhibited a linear response over 5-1000 μg L-1 with a limit of detection of 0.26 μg L-1 and good repeatability. Furthermore, smartphone-based RGB analysis provided a portable alternative for signal readout, achieving a detection limit of 3.70 μg L-1. The method was successfully applied to commercial cosmetic samples, showing good agreement with high-performance liquid chromatography. These results highlight the potential of the biodegradable 3D-printed ECL microcell as a simple, sustainable, and accessible platform for portable analytical applications.

PubMedExpert opinion on emerging drugs2026-07-17

Drug discovery progress in targeting the renin - angiotensin - aldosterone system for heart failure.

Choudhary Diksha D, Bansal Nisha N, Kumar Bhupinder B

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about INJEX system